Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum
-
MedMen Announces Layoffs and Overall Plan to Achieve Positive EBITDA
-
T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
-
Form 8.3 - Accesso Technology Group plc
-
Shockwave Medical (SWAV) Prices 2.48M Share Common Offering at $36.25/Sh
-
Shockwave Announces Pricing of Public Offering of Common Stock
-
Shockwave Announces Pricing of Public Offering of Common Stock
-
Middlefield Global Real Asset Fund Announces Exchange Ratios
-
Chembio Diagnostics to Participate in Upcoming Investor Conferences
-
Youth INC Celebrates 25 Years of Impact Raising Over $3M for New York City Kids
-
H2O Innovation Completes $22 M Equity Offering
-
Obalon To Present at Two Upcoming Institutional Investor Conferences
-
SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019
-
Obalon To Present at Two Upcoming Institutional Investor Conferences
-
STRATA Skin Sciences to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Avante Logixx Secures up to $18.0 million in Financing from Well Known Canadian Investor and To Expand Nationally with Acquisition of A.S.A.P. Secured Inc.
-
Form 8.3 - Accesso Technology Group plc
-
Starlight Hybrid Global Real Assets Trust Announces Private Placement
-
TELA Bio Announces Closing of Initial Public Offering of Common Stock
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
TELA Bio Announces Closing of Initial Public Offering of Common Stock
-
Tactile Medical to Participate in Two Upcoming Investor Conferences in November and December
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
Palatin Technologies (PTN) PT Lowered to $4 at Canaccord Genuity
-
Canaccord Genuity Downgrades Yellow Pages Ltd. (Y:CN) (YLWDF) to Hold
-
Forty Seven Inc. (FTSV) PT Lowered to $22 at Canaccord Genuity
-
Gryphon Networks Announces Strategic Investment From Sverica Capital Management
-
Net Asset Value(s)
-
New Water Capital Announces Recapitalization of Two Tier III Electronics Manufacturing Services (EMS) Providers
-
Stradigi AI Raises $53 Million CAD Series A Funding to Fuel North American Expansion
-
ATEC to Participate in The Canaccord Genuity MedTech and Diagnostics Forum and The Piper Jaffray 31st Annual Healthcare Conference
-
InMode to Present at Canaccord Genuity MedTech & Diagnostics Forum
-
Form 8.3 - Accesso Technology Group plc
-
Aspen Group (ASPU) PT Raised to $9 at Canaccord Genuity
-
Form 8.3 - Accesso Technology Group plc
-
Lions Gate Entertainment Corp. (LGF-b) PT Lowered to $15 at Canaccord Genuity
-
TELA Bio (TELA) IPO Opens Higher
-
Transaction in Own Shares
-
Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
TELA Bio, Inc. (TELA) Prices 4M Share IPO at $13/Sh
-
Closed Period Notification
-
Form 8.3 - Accesso Technology Group plc
-
TELA Bio Announces Pricing of Initial Public Offering of Common Stock
-
TELA Bio Announces Pricing of Initial Public Offering of Common Stock
-
Digi Int'l (DGII) to Acquire Opengear
-
KORU Medical Systems to Present at November Investor Conferences
-
Digi International To Acquire Opengear
-
Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019
-
Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019

